Abstract
AbstractLung cancer (LC) is among the malignant tumors with the highest disease burden in the world, accounting for approximately 11.4% of all cancer cases, and LC was the 2nd most common type of malignant tumor. The editing of the CACA Guidelines for Holistic Integrative Management of Lung Cancer aimed to facilitate the enhancement of lung cancer diagnosis and comprehensive treatment in China.The CACA Guidelines for Holistic Integrative Management of Lung Cancer include the epidemiology, the early detection, the comprehensive diagnosis, the treatment (including surgical, medical and radiological treatment), rehabilitation, and some general principles for both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).The main objective of this guideline is to standardize the clinical diagnosis and treatment process of lung cancer, with a specific focus on enhancing the management of this disease in China.
Publisher
Springer Science and Business Media LLC
Reference184 articles.
1. Lyon, F. and I.A.f.R.o. Cancer, Cancer today. Available from: https://gco.iarc.fr/today/home.
2. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2020.Available from: http://ghdx.healthdata.org/gbd-results-tool.
3. Zhang S, et al. Cancer incidence and mortality in China, 2015. J Nat Cancer Center. 2021;1(1):2–11.
4. Sun KX, et al. The incidence and mortality of lung cancer in China, 2014. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 2018;40(11):805–11.
5. Zeng H, et al. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6(5):e555–67.